Furosemide Tablet
Product Images NDC 71335-2317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 71335-2317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 01)

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 01)
Chemical structure diagram of the active ingredient Furosemide, showing its molecular composition including a benzene ring, sulfonamide group, chloro substituent, carboxyl group, and furan ring.*
FDA Label Image

Label (Lbl713352317)

Label (Lbl713352317)
Label for Furosemide Tablets, USP 40 mg oral tablets. The label shows the NDC number 71335-2317-1 and specifies a container of 40 tablets. It includes storage instructions (20° to 25°C, protect from light) and safety warnings about child-resistant packaging and seal integrity. The labeler is Bryant Ranch Prepack, and the manufacturer is Graviti Pharmaceuticals Private Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.